Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonists.

J Med Chem 2006 Dec;49(25):7278-89

Department of Chemistry, Adolor Corporation, 700 Pennsylvania Drive, Exton, Pennsylvania 19341, USA.

The series of trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidines have been widely investigated as opioid receptor antagonists. One of our research goals was to explore the bioactive conformation of the N-phenethyl trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine derivative 3, prototypical mu-opioid antagonist in this series. In this effort, the rotational degrees of freedom of the N-substituent of 3 were limited by incorporation of an ethylene bridge between the piperidine 2- or 6-position of 3 and the benzylic position of the N-phenethyl moiety. The overall modification led to a novel series of fused bicyclic derivatives of the octahydroquinolizine chemical class, conformationally restricted analogue of 3. The constrained analogues 6 and 9 showed high affinity toward the mu-opioid receptor. Compound 6 was found to be a mu-opioid antagonist, whereas the constrained analogue 9 displayed potent mu-agonist activity in vitro. This study provides additional information about the molecular determinants for mu recognition, the structural features affecting ligand binding, and the structure function relationships.

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm060486fDOI Listing
December 2006
7 Reads

Publication Analysis

Top Keywords

mu-opioid antagonist
8
receptor antagonists
8
bioactive conformation
8
mu-opioid receptor
8
6-position benzylic
4
study additional
4
benzylic position
4
vitro study
4
activity vitro
4
modification led
4
moiety modification
4
n-phenethyl moiety
4
piperidine 6-position
4
position n-phenethyl
4
bridge piperidine
4
n-substituent limited
4
receptor compound
4
freedom n-substituent
4
degrees freedom
4
limited incorporation
4

Altmetric Statistics

Similar Publications